Granules India informs about press release

05 Mar 2026 Evaluate
Granules India has enclosed a copy of Press Release titled ‘Granules India’s Packaging Facility in US gets FDA EIR with No Action Indicated Status’.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

576.80 3.00 (0.52%)
06-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.95
Dr. Reddys Lab 1303.90
Cipla 1321.75
Zydus Lifesciences 912.95
Lupin 2344.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×